Terguride

特麦角脲

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameTerguride

Drug Alias NameDironyl maleate麦角乙脲TerguridumDironylTransdihydrolisuride +[11]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine D2 receptor agonists

TargetsDopamine D2 receptor

Therapy Area/IndicationsHyperprolactinemia

Global Approved IndicationsHyperprolactinemia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved Date1994/01/01

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsHyperprolactinemia

Inactive IndicationsN/A

ATC CodeG02CB06